Relationship of autoantibodies against angiotensin Ⅱ-1 receptor, α1-and 1-adrenergic receptors with thyrotoxicosis heart disease
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1000-6699.2013.09.010
   		
        
        	
        		- VernacularTitle:血管紧张素Ⅱ1型受体、α1和β1肾上腺素能受体自身抗体与甲状腺毒症性心脏病相关性分析
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Jinling XU
			        		
			        		;
		        		
		        		
		        		
			        		Linshuang ZHAO
			        		
			        		;
		        		
		        		
		        		
			        		Min WANG
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Thyrotoxicosis heart disease;
			        		
			        		
			        		
				        		Angiotensin Ⅱ-1 receptor;
			        		
			        		
			        		
				        		α1-adrenergic receptor;
			        		
			        		
			        		
				        		β1-adrenergic receptor;
			        		
			        		
			        		
				        		Autoantibodies
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Endocrinology and Metabolism
	            		
	            		 2013;29(9):774-778
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To explore the relationship of autoantibodies against G protein coupled angiotensin Ⅱ-1 receptor (AT1 R),α1-adrenergic and β1-adrenergic receptors (α1 R and β1 R) with thyrotoxicosis heart disease (THD).Methods The epitopes of the second extracellular loop ofAT1 R (165-191),α1 R (192-218),and β1 R(197-222) were synthesized for screening autoantibodies from 277 participants by ELISA.237 patients with thyrotoxicosis were subdivided into thyrotoxicosis treatment group (n =148) and thyrotoxicosis recovery group (n =89),or into THD group (n =46) and simple hyperthyroidism group (n =191).40 healthy subjects were served as control group.Results (1) The positive rates of autoantibodies against AT1 R,α1 R and β1 R in thyrotoxicosis patients were higher than those in the control subjects (31.6% vs 12.5%,27.8% vs 10.0%,and 23.6% vs 7.5%,all P<0.05).The positive rates of the three autoantibodies in the patients with Graves' disease were higher compared with thyrotoxicosis caused by other reasons (36.3% vs 19.7%,32.2% vs 16.7%,and 28.1% vs 12.1%,all P<0.05).(2) In thyrotoxicosis treatment group,the positive rates of autoantibodies against AT1 R and α1 R were higher than those in the hyperthyroidism recovery group (40.5% vs 16.9% and 33.1% vs 19.1%,both P<0.05).(3) The incidence of autoantibodies against AT1 R and α1 R in THD were significantly higher compared with simple hyperthyroidism (52.2% vs 26.7% and 43.5% vs 24.1%,both P<0.05).Conclusions Autoantibodies against AT1 R,α1 R,and β1 R may play important roles in the pathogenesis of hyperthyroidism,which may be involved in the progression of THD.